269 studies found for:    "Expanded Access" [STUDY-TYPES]
Show Display Options
RSS Create an RSS feed from your search for:
"Expanded Access" [STUDY-TYPES]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells
Conditions: Endometrial Cancer;   Colon Cancer
Intervention: Other: Tissue sample from tumor
2 Approved for marketing A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: trastuzumab-MCC-DM1
3 Available Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan
Condition: Prostate Cancer
Intervention: Drug: [11C]Acetate
4 No longer available Aprotinin US Special Access Protocol
Condition: Postoperative Hemorrhage
Intervention: Drug: Aprotinin (Trasylol, BAYA0128)
5 Temporarily not available Clopidogrel Resistance and the Possibility of Its Affection
Condition: Coronary Artery Disease
Intervention: Drug: clopidogrel
6 No longer available Atazanavir for HIV Infected Individuals: An Early Access Program
Condition: HIV Infections
Intervention: Drug: Atazanavir (BMS-232632)
7 Approved for marketing Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab
8 Temporarily not available A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.
Condition: Healthy
Intervention: Drug: HX-1171
9 Temporarily not available Clofazamine in the Long Term Treatment of Leprosy, Phase III
Condition: Leprosy
Intervention: Drug: clofazamine
10 No longer available A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: Open Label Treatment Access: Maraviroc
11 Available Expanded Access Protocol of Blinatumomab in Pediatric and Adolescent Subjects With Relapsed and/or Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Condition: Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)
Intervention: Drug: Blinatumomab
12 Approved for marketing Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
Condition: Iron Overload
Intervention: Drug: deferiprone
13 No longer available Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L)
Condition: Non-small Cell Lung Cancer
Intervention: Biological: Lucanix® (belagenpumatucel-L)
14 Available Accuracy and Reliability of GSA for Remnant Liver Function
Condition: Both Benign and Malignant Liver Mass
Intervention: Device: 99mTc-GSA
15 Available Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome
Condition: Lambert Eaton Myasthenic Syndrome
Intervention: Drug: 3, 4-Diaminopyridine
16 Available Keratoconus and Ectasia Treatment Plan
Conditions: Keratoconus;   Ectasia
Interventions: Other: Riboflavin Solution;   Device: UV-X Illumination System
17 No longer available Treatment Protocol of Replagal for Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Biological: agalsidase alfa
18 No longer available Use of the ELAD® in Patients With Liver Failure to Provide Expanded Access With Cost Recovery
Condition: Liver Failure
Intervention: Device: ELAD®
19 No longer available Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)
Condition: Renal Failure
Intervention: Biological: Biological/Vaccine: Enriched Hematopoetic Stem Cell Transplant
20 No longer available Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients
Condition: Lung Transplant
Intervention: Drug: Cyclosporine Inhalation Solution

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years